期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

经皮冠状动脉介入术后支架内血栓对临床预后的影响 被引量：5

下载PDF
导出
摘要 目的评价经皮冠状动脉介入(PCI)治疗后支架内血栓形成的危险因素及其对临床预后的影响。方法入选我院资料库登记成功实施PCI治疗的1283例患者。男860例,女423例,年龄(61.2±8.3)岁(14～84岁)。围手术期采用阿司匹林、氯吡格雷/噻氯匹定、低分子肝素/普通肝素进行标准的三联抗血小板、抗凝治疗。PCI手术方案:经股(桡)动脉入路,按标准的PCI手术规范治疗。平均随访(12±8)月(4-23月)。结果在1283例常规PCI患者中发生12例次支架内血栓形成,发生率为0.94%(12/1020)。其中急性支架内血栓1例,亚急性血栓9例,延迟血栓2例。合并危险因素,急性冠脉综合症(ACS)10例,弥漫长病变8例,心功能不全8例。临床转归:8例治愈出院,死亡4例。死亡的4例均为心绞痛并LAD支架内血栓形成,3例合并严重心功能不全。结论支架内亚急性血栓多发生于ACS、弥漫长病变、支架贴壁不良及心功能不全患者。合并不稳定性心绞痛、心功能不全、前降支支架内血栓形成是导致患者死亡的主要原因之一。
作者 修建成 侯玉清 黄铮 郭志刚 周忠江 贾满盈 吴平生 许顶立
机构地区 南方医科大学南方医院心内科
出处 《南方医科大学学报》 CAS CSCD 北大核心 2009年第1期165-166,169,共3页 Journal of Southern Medical University
关键词 经皮冠状动脉介入 血栓治疗 前降支支架
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献10

  • 1调查协作组,霍勇.中国多中心药物洗脱支架急性或亚急性血栓的调查[J].中国介入心脏病学杂志,2005,13(3):131-134. 被引量：24
  • 2Moussa I. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation [ J ]. Circulation, 1999, 99: 2364-6.
  • 3Schulen H, Kastrati A, Dirschinger J, et al. Intracoronary stenting and risk for major adverse cardiac events during the first month[J]. Circulation, 1998, 98:104-11.
  • 4Cheneau E, Leborgne L, Mintz GS, et al. Predictor of subacute stent thrombosis: result of a systematic intravascular ultrasound study [J]. Circulation, 2003, 108: 43-7.
  • 5Honda Y, Fitzgerald PJ. Stent thrombosis: an issue revisited in a changing world [ J ]. Circulation, 2003, 108: 2-5.
  • 6Kereiakes DJ. Coronary small-vessel stenting in the era of drug elution[J]. Rev Cardiovasc Med, 2004, 5 (Suppl 2): S34-45.
  • 7Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and longterm outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents [J]. Circulation, 2006, 113: 1108-13.
  • 8Giuseppe GL, Biondi Z, Marzia L, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50279 patients at risk for coronary artery disease [J ]. Eur Heart J, 2006, 27: 2667-74.
  • 9Montalescot G, Sideris G, Meuleman C, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION(Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial [J]. J Am Coil Cardiol, 2006, 48:931-8.
  • 10Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents[ J]. J Am Coil Cardiol, 2006, 48: 2584-91.

二级参考文献2

  • 1Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 2004,109:190-195.
  • 2Moreno R, Fernandez C, Alfonso F, et al. Thrombosis after drug-eluting vs bare-metal stent implantation: a meta-analysis from 10 randomized trials including 5030 patients. Circulation, 2004,110:III-687. Abstract 3181.

共引文献23

同被引文献47

  • 1牛春燕,关丽,罗金燕.维吾尔族健康人群CYP2C19基因多态性分析[J].新疆医科大学学报,2005,28(3):247-249. 被引量：8
  • 2胡祥鹏,黄庆科,马升高,吴明,吴金明,吴建胜.浙江省汉族人群CYP2C19基因多态性的分布特征[J].浙江医学,2009(10). 被引量：7
  • 3鲁润秋,吴强,张陈匀,刘志琴,李世英,王咏梅,陈瑾,梁青龙,刘然,王华义,周松.药物洗脱支架内急性和亚急性血栓形成6例报告[J].贵州医药,2012,36(3):250-251. 被引量：1
  • 4邢东亮,宋东奎,张莉蓉.膀胱癌患者细胞色素氧化酶P450 2C19基因多态性分析[J].郑州大学学报（医学版）,2006,41(2):285-287. 被引量：4
  • 5O'Donoghue M L, Braunwald E, Antman E M, et al. Phar- maccynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton- pump inhibitor:an analy sis of two randomid trialsJ. Lancet, 2009, 374(9694): 989.
  • 6Angiolillo D J, Gibson C M, Cheng S, et al. Differential ef- fects of omeprazole and pantoprazole on the pharmacodyna- mies and pharmaookineties of clopidogrel in healthy subjects: 'andomized, placebo- controlled, erosver comparin stud- ies[J]. Clin Pharmacol Ther, 2011, 89(1 ) : 65.
  • 7杜宏伟.天津地区汉族人群细胞色素P4502C19基因多态性分析[J].健康必读,2012,11(7):33.
  • 8Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocarc- tion with ST-segment elevation [ J ]. N Engl J Med, 2005, 352(12) :1179.
  • 9Buonamici P, Marcucci R, Migliorini A, et al. Impact of platelet reactivity after clopidogrel administration on drug- eluting stent thrombosis [ J ]. J Am Coil Cardiol, 2007,49 (24) :2312.
  • 10Varenhorst C, James S, Erlinge D, et al. Genetic variation of CYP2C19 affects both pharmaeokinetic and pharmacodyna- mic responses to clopidogrel but not prasugrel in aspirin- treated patients with coronary artery disease[ J]. Eur Heart J,2009,30 ( 14 ) : 1744.

引证文献5

二级引证文献35

南方医科大学学报
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部